Recent Finacing
Recent Raise
Iaso Therapeutics develops a customizable bacteriophage mQβ vaccine and drug-delivery platform that conjugates diverse antigens to enhance immune responses for human and animal vaccines.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Iaso Therapeutics.
